Randomised Controlled Trial of Dexmedetomidine Sedation Combined Suprascapular and Axillary Nerve Blocks for Analgesia in Arthroscopic Shoulder Surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052420

Enrollment

Unknown

Registered

2021-10-25

Start date

2018-09-01

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroscopic shoulder surgery.

Interventions

Test Group:Dexmedetomidine sedation combined with suprascapular nerve combined with axillary nerve block

Control group:Tracheal intubation general anesthesia combined with interscalene brachial plexus block

Eligibility

Sex/Gender

All

Age

27 Years to 58 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18-60 years; 2. American Society of Anesthesiologists ASA grade I-II; 3. Shoulder arthroscopy surgery is optional.

Exclusion criteria

Exclusion criteria: 1. Cerebrovascular disease; 2. Orthostatic hypotension; 3. Allergic to local anesthetic drugs; 4. Mental illnesses; 5. History of drug abuse; 6. Damaged, deformed or infected puncture site.

Design outcomes

Primary

Measure	Time frame
Mean arterial pressure;Cerebral oxygen saturation;Visual Analog Scale;	—

Secondary

Measure	Time frame
Complications;	—

Countries

China

Contacts

Public ContactWang Chuting

Zhangzhou Hospital of Fujian Province

chuting1207@163.com+86 15260659490

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026